Holdings

Kynam Capital Management, LP

As of Sep 30, 2026, Kynam Capital Management, LP reported 30 positions worth US$1.68B. Largest: Legend Biotech Corp., Celldex Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Legend Biotech Corp.9.15MUS$182MnewSep 30, 2026
Celldex Therapeutics, Inc.5.07MUS$164M−257KSep 30, 2026
Syndax Pharmaceuticals, Inc.8.15MUS$153M+100KSep 30, 2026
Vaxcyte, Inc.2.61MUS$148M−314KSep 30, 2026
Viridian Therapeutics, Inc.6.15MUS$127M−306KSep 30, 2026
Cogent Biosciences, Inc.3.79MUS$121M+125KSep 30, 2026
Travere Therapeutics, Inc.2MUS$118Mno changeSep 30, 2026
Vera Therapeutics, Inc.3MUS$96.9M+110KSep 30, 2026
Beam Therapeutics Inc.3.93MUS$96.2M+1.09MSep 30, 2026
CytomX Therapeutics, Inc.21.1MUS$57.5M−562KSep 30, 2026